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Abstract The effect of fructose 2,6-bisphosphate on the 
dynamics of the 6-phosphofructo-l-kinase/fructose-l,6-bisphos- 
phatase cycle is investigated in a cell-free extract of rat liver 
under steady-state conditions. Bistability emerges on the basis of 
the reciprocal allosteric modulation of 6-phosphofructo-l-kinase 
and fructose-l,6-bisphosphatase. Under conditions of bistability 
fructose 2,6-bisphosphate may cause transitions between alter- 
native steady states. However, in contrast to what is frequently 
observed in bistable systems, within a broad range of experi- 
mental conditions these transitions proceed irreversibly from 
states with high ATP to states characterized by low ATP. 
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1. Introduction 
Fructose 2,6-bisphosphate (Fru-2,6-Pz) is the most powerful 
~ctivator of 6-phosphofructo-l-kinase (6PF-I-K, EC 2.7.1.11) 
~nd an inhibitor of fructose-l,6-bisphosphatase (Fru-l,6- 
t'2ase, EC 3.1.3.11) [1-5]. It acts as an important modulator 
~.f glycolysis and gluconeogenesis. In liver, synthesis and deg- 
radation of Fru-2,6-P2 are catalyzed by a bifunctional en- 
zyme, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 
16PF-2-K/Fru-2,6-P2ase, EC 2.7.1.105/3.1.3.46) [6]. The two 
tnzyme activities are reciprocally regulated by cAMP-depen- 
,~ent phosphorylation and allosteric modulators [7,8]. Gene 
txpression of the bifunctional enzyme is subject o multihor- 
~aonal regulation [9]. 
The steady-state l vel of Fru-2,6-P2 is determined by the 
~atio between 6PF-2-K and Fru-2,6-P2ase activities. Appro- 
t~riate concentration changes of Fru-2,6-P2 may revert the 
~iirection of substrate flux in the 6PF-1-K/Fru-l,6-P2ase cycle 
.... nd thereby contribute to switch between glycolysis and glu- 
, oneogenesis and to ensure efficient glycolytic or gluconeo- 
!~:enic pathway fluxes [9-12]. 
Some insights into the regulatory potential of Fru-2,6-P2 
'vere gained from in vitro studies allowing the separate inves- 
tigation of the cycles formed by 6PF-2-K/Fru-2,6-P2ase and 
~,PF-1-K/Fru-l,6-P2ase. In the co-operation between 6PF-2-K 
,~nd Fru-2,6-Pzase a non-linear dynamic trigger is formed 
which causes a threshold response of Fru-2,6-P2 with respect 
~.o the concentration of fructose 6-phosphate and the phos- 
!~horylation state of the bifunctional enzyme [13]. Fru-2,6-P2, 
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in turn, may affect non-linear dynamic structures in the 6PF- 
1-K/Fru-l,6-P2ase cycle which are the result of the reciprocal 
allosteric modulation of 6PF-1-K and Fru-l,6-P2ase by AMP, 
fructose 6-phosphate (Fru-6-P), and fructose 1,6-bisphosphate 
(Fru-l,6-P2). Fru-2,6-P2 was also shown to modulate oscilla- 
tory states in glucose metabolism [14--16]. 
In the present paper the effect of Fru-2,6-Pz on dynamic 
phenomena related to bistability in the 6PF-l-K/Fru-l,6-P~ase 
cycle is investigated in a cell-free xtract of rat liver. 
Conditions are chosen under which 6PF-2-K/Fru-2,6-P2ase 
is omitted and the concentration of Fru-2,6-P2 becomes ad- 
justable xperimentally. The occurrence of bistability has been 
shown under these conditions [17]. In this paper it will be 
demonstrated that Fru-2,6-P2 may cause transitions between 
alternative and functionally different states of the 6PF-1-K/ 
Fru-l,6-P2ase cycle. However, in fundamental contrast o 
what is frequently observed in bistable systems, within a 
broad range of experimental conditions these transitions are 
irreversible. This result provides an experimental verification 
in a biochemical reaction system of the hitherto theoretically 
predicted phenomenon of irreversible transitions [18]. 
2. Materials and methods 
2.1. Preparation of cell-free xtracts 
Male albino Wistar rats, weighing 200-280 g and fed normally, 
were used. Cytosol was prepared from liver as described previously 
[18]. For adjustment of a defined ratio of 6PF-1-K/Fru-l,6-P~ase th  
extracts were supplemented by rat liver 6PF-1-K partially purified 
according to Kagimoto and Uyeda [19] and Van Schaftingen tal. [2]. 
2.2. Experimental study of the 6PF-1-K/Fru-l,6-P2ase cycle 
The experiments were carried out in a buffer consisting of 50 mM 
HEPES-KOH (pH 7.2), 100 mM KCI, 5 mM KH2PO4, 2.5 mM 
MgCI2, 1 mM NH4CI, 0.2 mM EGTA, 0.25 mM PMSF, 2.5 mM 
DTT, and 1 I.tM E-64 at 37°C. The experimental set-up was described 
in detail elsewhere [17]. The reaction chamber isfed continuously with 
cell-free xtract and substrates from two reservoirs through two sepa- 
rate channels. Glycolytic flow was restricted to the upper part of the 
pathway by omission of NAD. The maximum activities of the en- 
zymes in the reaction chamber, the concentration f the substrates 
in the influx solution, and the residence time characterizing the flow 
rate through the reactor ('~=reactor v lume/pump rate) can experi- 
mentally be varied. The state of the system is defined by the actual 
metabolite concentrations which are determined in samples taken 
from the efflux solution leaving the reaction chamber. Hexose mono- 
phosphates, Fru-l,6-P2, ATP, and pyruvate (Pry) were determined by 
standard enzymatic methods [20]. Fru-2,6-P2 was determined by the 
pyrophosphate-dependent 6PF-1-K activation assay [21]. 
2.3. Mathematical modelling 
The dynamics of the reaction web formed in the cell-free xtract is 
described by a set of ordinary differential equations for the metabolite 
concentrations 
dx/dt - f (x,p)  
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which take into consideration the substrate conversion by the enzymes 
involved as well as flow processes which are related to the experimen- 
tal design, x denotes the vector of the metabolite concentrations and p 
the vector of control parameters of the system [17]. Qualitative dy- 
namic properties of the reaction system as the multiplicity and the 
stability of the stationary states were analyzed [22]. 
3. Resu l ts  
In Fig. 1 the results of an experiment are shown in which 
bistability is demonstrated. The experiment was started with 
high initial concentrations of PEP and ATP without added 
Fru-2,6-P2. A stable stationary state is approached in phase I 
which is characterized by high concentrations of hexose 
monophosphates and ATP. The latter is connected with low 
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Fig. 1. Experimental evidence for an irreversible transition induced 
by fructose 2,6-bisphosphate: Time evolution of metabolite concen- 
trations in rat liver cytosol. (A) e, ([Glc-6-P]+[Fru-6-P]); (3, [Fru- 
1,6-P2]. (B) I ,  [ATP]. (C) ~,, [Pry]. (D) , ,  [Fru-2,6-P2]. Control 
parameters - enzyme activities: V6e~-I-K =0.38 U/ml; 
V~,.u 1,6-~2~ =1.1 U/ml; Vpyruwtek inaze  = 39 U/ml; substrate supply: 
([Glc-6-P] + [Fru-6-P])iy = 2 mM; [ATP]IN = 1 mM; [PEP]Ir~ = 11 
mM; x=41 min. Phases I and III: [Fru-2,6-P2]i~=0; phase II: 
[Fru-2,6-P2]IN = 10 ~tM. 
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Fig. 2. Low concentrations of Fru-2,6-P2 are not capable of induc- 
ing transitions to low-energy states: Time evolution of metabolite 
concentrations in rat liver cytosol. (A) O, ([Glc-6-P]+ [Fru-6-P]); ©, 
[Fru-l,6-P2]. (B) I ,  [ATP]. (C) zx, [Prv]. Experimental conditions 
refer to those in Fig. 1 with the exception of [PEP]IN = 7 mM. 
Phases I and III: [Fru-2,6-Pz]ir~=0; phase II: [Fru-2,6-P2]iN=0.2 
~tM. 
concentrations of ADP and AMP and, correspondingly, a 
high adenylate nergy charge. This state is therefore denoted 
as high-energy stationary state (SH). In phase II the system 
was perturbed by the addition of Fru-2,6-P2 to both the influx 
and the reaction chamber. This causes primarily efficient acti- 
vation of 6PF-1-K and inhibition of Fru-l,6-P2ase. In the 
beginning of phase II, transitorily homeostasis of ATP is ob- 
served, which is at the expense of PEP. When the rephospho- 
rylation capacity of pyruvate kinase is exhausted, the concen- 
trations of ATP and hexose monophosphates decrease. A 
steady state characterized by low concentrations of ATP 
and hexose monophosphates is approached. It differs qualita- 
tively from that approached in phase I and is denoted as the 
low-energy stationary state (SL). In phase III, the experimen- 
tal conditions applied in phase I were restored. Fru-2,6-P2 is 
removed from the reaction chamber according to first-order 
kinetics. Nevertheless, also in the absence of Fru-2,6-P2 a low- 
energy stationary state is approached which differs qualita- 
tively from that observed in phase I. 
The qualitative dynamic properties of the stationary states 
as calculated from a mathematical model of the reaction net- 
work are shown in Fig. 3A. In the absence of Fru-2,6-P2 two 
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i:ig. 3. Stationary metabolite concentrations as a function of [Fru- 
I:,6-P2]IN. The control parameters efer to Figs. 1A and 2B. SH, 
ifigh-energy steady states; SL, low-energy states; Ss, saddle points. 
I ,  limit points; solid curves, stable stationary states; dashed curves, 
mstable steady states. 
alternative stationary states (SH and SL)  coexist with a saddle 
)oint (Ss). Which of the stable states is actually approached 
depends on the initial conditions or on the history of the 
.,ystem. The initial metabolite concentrations used in Fig. l 
::nsure the attainment of an high-energy stationary state in 
3hase I. By the addition of Fru-2,6-P2 in phase II of the 
,:,xperiment a limit point is crossed, at which the high-energy 
~ranch of stationary states disappears. Hence, the metabolic 
~tate switches to the remaining low-energy branch of station- 
Lry states. At decreasing levels of Fru-2,6-P2 the metabolic 
~tates rest on the low-energy branch of stationary states which 
)ersists even in the absence of Fru-2,6-P2. 
In Fig. 2 the results of a control experiment are shown 
schich differs from that in Fig. 1 essentially by the lower influx 
:oncentration of PEP used throughout the experiment and the 
nuch lower concentration of Fru-2,6-P2 applied in phase II. 
iln accordance with model calculations shown in Fig. 3B this 
:oncentration of Fru-2,6-P2 is unable to induce a transition 
owards the low-energy stationary state. Hence, in phase III 
he same high-energy steady state as that approached in phase 
i is attained. 
4. Discussion 
The investigation of glucose metabolism in cell-flee extracts 
mables the analysis of well-defined reaction etworks by add- 
~ng and/or removing enzymes and cofactors and by determin- 
ang the composition of substrate supply. Removal of 6PF-2- 
K/Fru-2,6-P2ase from the cell-flee extract simplifies the reac- 
tion web by excluding the interaction of the Fru-6-P/Fru-l,6- 
P2 and the Fru-6-P/Fru-2,6-P2 cycle and makes Fru-2,6-Pz 
experimentally adjustable. This reduces the biochemical and 
dynamic complexity and provides the basis to study experi- 
mental paradigms of stepwise increasing complexity. 
Already in this simplified metabolic web complex dynamic 
pattern as multistability emerge [17]. Fru-2,6-P2 is able to 
trigger transitions between alternative stationary states. In 
contrast to what is observed in classical bistable systems, 
only one limit point can be passed by changes of the concen- 
tration of Fru-2,6-P2. Hence, variations of Fru-2,6-P2 may 
cause transitions from the high-energy branch of stationary 
states (SH) towards the low-energy branch of stationary states 
(SL), while the reverse transition cannot be attained by any 
change of Fru-2,6-P2. The transitions S~ =SL induced by 
Fru-2,6-P2 are irreversible. Consequently, from any state on 
the low-energy branch of steady states transitions to high-en- 
ergy steady states can only be induced by mechanisms which 
do not act via Fru-2,6-P2 on the 6PF-1-K/Fru-l,6-P2ase cycle. 
Possible candidates for such mechanisms acting in vivo are 
changes in the concentrations of adenine nucleotides or 
changes of the substrate supply. 
The occurrence of irreversible transitions in bistable meta- 
bolic systems creates a qualitatively new dynamic pattern. 
Irreversible transitions induce a preference between coexisting 
functionally different stationary states in that the system is 
finally arrested in one stationary mode. To overcome such 
restrictions in cellular metabolism, mechanisms of multiple 
control of substrate cycles had to be developed to rescue dy- 
namic flexibility. 
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